CliffBio
small molecule

OTOVEL

CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE

Loss of exclusivityMarch 2030latest FDA-listed patent expiry
CompanyLABORATORIOS SALVAT SA

Drug detail

Brand nameOTOVEL
Active ingredientCIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE
StrengthEQ 0.3% BASE;0.025%
Dosage formSOLUTION/DROPS
RouteOTIC
ModalitySmall molecule
FDA approvalApril 2016
Marketing statusRX

Listed patents

PatentExpiresType
8932610March 2030product

More from LABORATORIOS SALVAT SA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

OTOVEL patent cliff — loss of exclusivity March 2030 | CliffBio